Synthesis and protective effects of novel salidroside analogues on glucose and serum depletion induced apoptosis in PC12 cells

Archiv der Pharmazie

Volumn 346, Issue 4, 2013, Pages 300-307

  Zhao, Yahong ^a   Ling, Yong ^a   Zhao, Jing ^a   Yuan, Ying ^a   Guo, Yibin ^a   Liu, Qiong ^a   Wu, Bingxin ^a   Ding, Zuoyou ^a   Yang, Yumin ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cerebral ischemia; Glucose and serum depletion; Neuroprotective effect; PC12 cells; Salidroside analogues

Indexed keywords

2 (3 ACETYL 4 METHOXYPHENYL) ETHYL BETA D GLUCOPYRANOSIDE; CASPASE 3; GLUCOSE; HOE 33342; NEUROPROTECTIVE AGENT; PROTEIN BAX; PROTEIN BCL 2; SALIDROSIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROPROTECTION; PC12 CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL SURVIVAL; GLUCOSE; GLUCOSIDES; NEUROPROTECTIVE AGENTS; PC12 CELLS; PHENOLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84876127316     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201200444     Document Type: Article

References (21)

1. C. D. Mathers, T. Boerma, D. Ma Fat, Br. Med. Bull. 2009, 92, 7-32.
2. K. H. Moley, M. M. Mueckler, Apoptosis 2000, 5, 99-105.
3. B. K. Siesjo, J. Neurosurg. 1992, 77, 337-354.
4. C. Stadelmann, H. Lassmann, Cell Tissue Res. 2000, 301, 19-31.
5. A. M. Diaz Lanza, M. J. Abad Martinez, L. Fernandez Matellano, C. Recuero Carretero, L. Villaescusa Castillo, A. M. Silvan Sen, P. Bermejo Benito, Planta. Med. 2001, 67, 219-223.
6. X. Hu, S. Lin, D. Yu, S. Qiu, X. Zhang, R. Mei, Cell Biol. Toxicol. 2010, 26, 499-507.
7. G. X. Mao, H. B. Deng, L. G. Yuan, D. D. Li, Y. Y. Li, Z. Wang, Biomed. Environ. Sci. 2010, 23, 161-166.
8. R. De Sanctis, R. De Bellis, C. Scesa, U. Mancini, L. Cucchiarini, M. Dacha, Biofactors 2004, 20, 147-159.
9. T. Wu, H. Zhou, Z. Jin, S. Bi, X. Yang, D. Yi, W. Liu, Eur. J. Pharmacol. 2009, 613, 93-99.
10. H. Wang, Y. Ding, J. Zhou, X. Sun, S. Wang, Phytomedicine 2009, 16, 146-155.
11. L. Zhang, H. Yu, X. Zhao, X. Lin, C. Tan, G. Cao, Z. Wang, Neurochem. Int. 2010, 57, 547-555.
12. Q. Y. Li, H. M. Wang, Z. Q. Wang, J. F. Ma, J. Q. Ding, S. D. Chen, Neurosci. Lett. 2010, 481, 154-158.
13. X. Chen, J. Liu, X. Gu, F. Ding, Brain Res. 2008, 1238, 189-198.
14. S. Yu, Y. Shen, J. Liu, F. Ding, J. Mol. Neurosci. 2010, 3, 321-331.
15. Y. Meng, Y. Guo, Y. Ling, Y. Zhao, Q. Zhang, X. Zhou, F. Ding, Y. Yang, Bioorg. Med. Chem. 2011, 19, 5577-5584.
16. H. S. Moon, S. I. Nam, S. D. Kim, D. Kim, B. J. Gwag, Y. A. Lee, S. H. Yoon, J. Pharm. Pharmacol. 2002, 54, 935-944.
17. M. Calvani, E. Arrigoni-Martelli, Int. J. Tissue React. 1999, 21, 1-6.
18. M. P. Mattson, W. Duan, W. A. Pedersen, C. Culmsee, Apoptosis 2001, 6, 69-81.
19. G. V. Putcha, M. Deshmukh, E. M. Jr. Johnson, J. Neurosci. 1999, 19, 7476-7485.
20. O. Bar-Am, O. Weinreb, T. Amit, M. B. Youdim, FASEB J. 2005, 19, 1899-1901.
21. M. Barczai Martos, F. Korosy, Nature (London) 1950, 165, 369.